echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > NEJM: The third dose of BNT162b2 vaccine is 95.3% effective in preventing new coronary pneumonia infection

    NEJM: The third dose of BNT162b2 vaccine is 95.3% effective in preventing new coronary pneumonia infection

    • Last Update: 2022-04-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    BNT162b2 vaccine (Pfizer-BioNTech) active immunization is an effective means to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe disease, and has been used in 117 countries in the Americas, the United Kingdom, Europe, Africa, Asia and Oceania State approved


    Immunization to prevent infection Recently, researchers examined the safety and efficacy of a booster shot of the BNT162b2 vaccine in people over 16 years of age



    The BNT162b vaccine is 95.


    BNT162b vaccine is 95.


    Ten months after the completion of the second dose of BNT162b2 vaccination, the effectiveness of the vaccine in preventing infection after the third dose reached 95.
    3%, and no new safety events occurred
    .
    Ten months after the completion of the second dose of BNT162b2 vaccination, the effectiveness of the vaccine in preventing infection after the third dose reached 95.
    3%, and no new safety events occurred
    .

    Original Source:
    Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.


    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.